Antidepressant Drugs Market Size By Drug Class (Selective Serotonin Reuptake Inhibitors {SSRIs}, Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) work in a similar way to SSRIs except that they inhibit the reuptake of both norepinephrine and serotonin {SNRIs}, Tricyclic Antidepressants), By Application (Major Depressive Disorder, Obsessive-compulsive Disorder, Generalized Anxiety Disorder, Panic Disorder), COVID-19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Report Content

Chapter 1   Methodology

1.1    Market definitions

1.2    Base estimates and working

1.2.1    North America

1.2.2    Europe

1.2.3    Asia Pacific

1.2.4    Latin America

1.2.5    Middle East and Africa (MEA)

1.3    Forecast calculations

1.4    Data validation

1.5    Data sources

1.5.1    Secondary

1.5.1.1    Paid sources

1.5.1.2    Unpaid sources

1.5.2    Primary

Chapter 2   Executive Summary

2.1    Antidepressant drugs industry 360⁰ synopsis, 2016 – 2027 (USD Million)

2.1.1    Business trends

2.1.2    Drug class trends

2.1.3    Application trends

2.1.4    Regional trends

Chapter 3   Antidepressant drugs Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2016 – 2027 (USD Million)

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rising prevalence of depression and anxiety disorders

3.3.1.2    Increasing investment in research and development

3.3.1.3    Growing awareness regarding treatment therapies and mental health

3.3.2    Industry pitfalls & challenges

3.3.2.1    Side effects associated with some antidepressant drugs

3.3.2.2    Customer preference for non-pharmacological therapeutics over pharmacological therapeutics

3.4    Growth potential analysis

3.4.1    By drug class

3.4.2    By application

3.5    COVID-19 impact analysis

3.6    Prescription pattern analysis

3.6.1    By gender

3.6.2    By Age group

3.7    Porter’s analysis

3.8    Competitive landscape, 2020

3.9    PESTEL analysis

Chapter 4   Antidepressant Drugs Market, By Drug Class

4.1    Key segment trends

4.2    Selective serotonin reuptake inhibitors (SSRIs)

4.2.1    Market size by region, 2016 – 2027 (USD Million)

4.3    Serotonin-norepinephrine reuptake inhibitors (SNRIs)

4.3.1    Market size by region, 2016 – 2027 (USD Million)

4.4    Tricyclic antidepressants

4.4.1    Market size by region, 2016 – 2027 (USD Million)

4.5    Others

4.5.1    Market size by region, 2016 – 2027 (USD Million)

Chapter 5   Antidepressant Drugs Market, By Application

5.1    Key segment trends

5.2    Major depressive disorder

5.2.1    Market size by region, 2016 – 2027 (USD Million)

5.3    Obsessive-compulsive disorder

5.3.1    Market size by region, 2016 – 2027 (USD Million)

5.4    Generalized anxiety disorder

5.4.1    Market size by region, 2016 – 2027 (USD Million)

5.5    Panic disorder

5.5.1    Market size by region, 2016 – 2027 (USD Million)

5.6    Others

5.6.1    Market size by region, 2016 – 2027 (USD Million)

Chapter 6   Antidepressant Drugs Market, By Region

6.1    Key regional trends

6.2    North America

6.2.1    Market size by country, 2016 – 2027 (USD Million)

6.2.2    Market size by drug class, 2016 – 2027 (USD Million)

6.2.3    Market size by application, 2016 – 2027 (USD Million)

6.2.4    U.S.

6.2.4.1    Market size by drug class, 2016 – 2027 (USD Million)

6.2.4.2    Market size by application, 2016 – 2027 (USD Million)

6.2.5    Canada

6.2.5.1    Market size by drug class, 2016 – 2027 (USD Million)

6.2.5.2    Market size by application, 2016 – 2027 (USD Million)

6.3    Europe

6.3.1    Market size by country, 2016 – 2027 (USD Million)

6.3.2    Market size by drug class, 2016 – 2027 (USD Million)

6.3.3    Market size by application, 2016 – 2027 (USD Million)

6.3.4    Germany

6.3.4.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.4.2    Market size by application, 2016 – 2027 (USD Million)

6.3.5    UK

6.3.5.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.5.2    Market size by application, 2016 – 2027 (USD Million)

6.3.6    France

6.3.6.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.6.2    Market size by application, 2016 – 2027 (USD Million)

6.3.7    Spain

6.3.7.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.7.2    Market size by application, 2016 – 2027 (USD Million)

6.3.8    Italy

6.3.8.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.8.2    Market size by application, 2016 – 2027 (USD Million)

6.3.9    Turkey

6.3.9.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.9.2    Market size by application, 2016 – 2027 (USD Million)

6.3.10    Sweden

6.3.10.1    Market size by drug class, 2016 – 2027 (USD Million)

6.3.10.2    Market size by application, 2016 – 2027 (USD Million)

6.4    Asia Pacific

6.4.1    Market size by country, 2016 – 2027 (USD Million)

6.4.2    Market size by drug class, 2016 – 2027 (USD Million)

6.4.3    Market size by application, 2016 – 2027 (USD Million)

6.4.4    China

6.4.4.1    Market size by drug class, 2016 – 2027 (USD Million)

6.4.4.2    Market size by application, 2016 – 2027 (USD Million)

6.4.5    India

6.4.5.1    Market size by drug class, 2016 – 2027 (USD Million)

6.4.5.2    Market size by application, 2016 – 2027 (USD Million)

6.4.6    Japan

6.4.6.1    Market size by drug class, 2016 – 2027 (USD Million)

6.4.6.2    Market size by application, 2016 – 2027 (USD Million)

6.4.7    Australia

6.4.7.1    Market size by drug class, 2016 – 2027 (USD Million)

6.4.7.2    Market size by application, 2016 – 2027 (USD Million)

6.4.8    South Korea

6.4.8.1    Market size by drug class, 2016 – 2027 (USD Million)

6.4.8.2    Market size by application, 2016 – 2027 (USD Million)

6.4.9    New Zealand

6.4.9.1    Market size by drug class, 2016 – 2027 (USD Million)

6.4.9.2    Market size by application, 2016 – 2027 (USD Million)

6.5    Latin America

6.5.1    Market size by country, 2016 – 2027 (USD Million)

6.5.2    Market size by drug class, 2016 – 2027 (USD Million)

6.5.3    Market size by application, 2016 – 2027 (USD Million)

6.5.4    Brazil

6.5.4.1    Market size by drug class, 2016 – 2027 (USD Million)

6.5.4.2    Market size by application, 2016 – 2027 (USD Million)

6.5.5    Mexico

6.5.5.1    Market size by drug class, 2016 – 2027 (USD Million)

6.5.5.2    Market size by application, 2016 – 2027 (USD Million)

6.5.6    Argentina

6.5.6.1    Market size by drug class, 2016 – 2027 (USD Million)

6.5.6.2    Market size by application, 2016 – 2027 (USD Million)

6.6    Middle East & Africa

6.6.1    Market size by country, 2016 – 2027 (USD Million)

6.6.2    Market size by drug class, 2016 – 2027 (USD Million)

6.6.3    Market size by application, 2016 – 2027 (USD Million)

6.6.4    South Africa

6.6.4.1    Market size by drug class, 2016 – 2027 (USD Million)

6.6.4.2    Market size by application, 2016 – 2027 (USD Million)

6.6.5    Saudi Arabia

6.6.5.1    Market size by drug class, 2016 – 2027 (USD Million)

6.6.5.2    Market size by application, 2016 – 2027 (USD Million)

Chapter 7   Company Profiles

7.1    Competitive dashboard, 2020

7.2    Eli Lilly & Company

7.2.1    Business overview

7.2.2    Financial data

7.2.3    Product landscape

7.2.4    Strategic outlook

7.2.5    SWOT analysis

7.3    Pfizer

7.3.1    Business overview

7.3.2    Financial data

7.3.3    Product landscape

7.3.4    Strategic outlook

7.3.5    SWOT analysis

7.4    Bristol Myers Squibb

7.4.1    Business overview

7.4.2    Financial data

7.4.3    Product landscape

7.4.4    Strategic outlook

7.4.5    SWOT analysis

7.5    GlaxoSmithKline Plc.

7.5.1    Business overview

7.5.2    Financial data

7.5.3    Product landscape

7.5.4    Strategic outlook

7.5.5    SWOT analysis

7.6    Patheon Inc.

7.6.1    Business overview

7.6.2    Financial data

7.6.3    Product landscape

7.6.4    Strategic outlook

7.6.5    SWOT analysis

7.7    Sandoz Inc.

7.7.1    Business overview

7.7.2    Financial data

7.7.3    Product landscape

7.7.4    Strategic outlook

7.7.5    SWOT analysis

7.8    N.V. Organon

7.8.1    Business overview

7.8.2    Financial data

7.8.3    Product landscape

7.8.4    Strategic outlook

7.8.5    SWOT analysis

7.9    Takeda Pharmaceuticals

7.9.1    Business overview

7.9.2    Financial data

7.9.3    Product landscape

7.9.4    Strategic outlook

7.9.5    SWOT analysis

7.10    Zhejiang NHU company Ltd.

7.10.1    Business overview

7.10.2    Financial data

7.10.3    Product landscape

7.10.4    Strategic outlook

7.10.5    SWOT analysis

7.11    Sun Pharmaceuticals Pvt. Ltd

7.11.1    Business overview

7.11.2    Financial data

7.11.3    Product landscape

7.11.4    Strategic outlook

7.11.5    SWOT analysis

7.12    Intracellular Therapies

7.12.1    Business overview

7.12.2    Financial data

7.12.3    Product landscape

7.12.4    Strategic outlook

7.12.5    SWOT analysis

7.13    Otsuka Pharmaceuticals

7.13.1    Business overview

7.13.2    Financial data

7.13.3    Product landscape

7.13.4    Strategic outlook

7.13.5    SWOT analysis

7.14    Janssen Pharmaceuticals (Johnson & Johnson)

7.14.1    Business overview

7.14.2    Financial data

7.14.3    Product landscape

7.14.4    Strategic outlook

7.14.5    SWOT analysis

7.15    Novartis AG

7.15.1    Business overview

7.15.2    Financial data

7.15.3    Product landscape

7.15.4    Strategic outlook

7.15.5    SWOT analysis

7.16    Opko health

7.16.1    Business overview

7.16.2    Financial data

7.16.3    Product landscape

7.16.4    Strategic outlook

7.16.5    SWOT analysis
 

Data Tables

TABLE 1    Antidepressant drugs market, 2016-2020 (USD Million)

TABLE 2    Antidepressant drugs market, 2021-2027 (USD Million)

TABLE 3    Antidepressant drugs market, by drug class, 2016-2020 (USD Million)

TABLE 4    Antidepressant drugs market, by drug class, 2021-2027 (USD Million)

TABLE 5    Antidepressant drugs market, by application, 2016-2020 (USD Million)

TABLE 6    Antidepressant drugs market, by application, 2021-2027 (USD Million)

TABLE 7    Antidepressant drugs market, by region, 2016-2020 (USD Million)

TABLE 8    Antidepressant drugs market, by region, 2021-2027 (USD Million)

TABLE 9    Industry impact forces

TABLE 10    Serotonin-norepinephrine reuptake inhibitors market size, by region, 2016-2020 (USD Million)

TABLE 11    Serotonin-norepinephrine reuptake inhibitors market size, by region, 2021-2027 (USD Million)

TABLE 12    Selective serotonin reuptake inhibitors market size, by region, 2016-2020(USD Million)

TABLE 13    Selective serotonin reuptake inhibitors market size, by region, 2021-2027(USD Million)

TABLE 14    Tricyclic antidepressants market size, by region, 2016-2020(USD Million)

TABLE 15    Tricyclic antidepressants market size, by region, 2021-2027(USD Million)

TABLE 16    Others market size, by region, 2016-2020(USD Million)

TABLE 17    Others market size, by region, 2021-2027(USD Million)

TABLE 18    Major depressive disorder market size, by region, 2016-2020(USD Million)

TABLE 19    Major depressive disorder market size, by region, 2021-2027(USD Million)

TABLE 20    Obsessive-compulsive disorder market size, by region, 2016-2020(USD Million)

TABLE 21    Obsessive-compulsive disorder market size, by region, 2021-2027(USD Million)

TABLE 22    Generalized anxiety disorder market size, by region, 2016-2020(USD Million)

TABLE 23    Generalized anxiety disorder market size, by region, 2021-2027(USD Million)

TABLE 24    Panic disorder market size, by region, 2016-2020(USD Million)

TABLE 25    Panic disorder market size, by region, 2021-2027(USD Million)

TABLE 26    Others market size, by region, 2016-2020(USD Million)

TABLE 27    Others market size, by region, 2021-2027(USD Million)

TABLE 28    North America market size, by country, 2016-2020(USD Million)

TABLE 29    North America market size, by country, 2021-2027(USD Million)

TABLE 30    North America market size, by drug class, 2016-2020(USD Million)

TABLE 31    North America market size, by drug class, 2021-2027(USD Million)

TABLE 32    North America market size, by application, 2016-2020(USD Million)

TABLE 33    North America market size, by application, 2021-2027(USD Million)

TABLE 34    U.S. market size, by drug class, 2016-2020(USD Million)

TABLE 35    U.S. market size, by drug class, 2021-2027(USD Million)

TABLE 36    U.S. market size, by application, 2016-2020(USD Million)

TABLE 37    U.S. market size, by application, 2021-2027(USD Million)

TABLE 38    Canada market size, by drug class, 2016-2020(USD Million)

TABLE 39    Canada market size, by drug class, 2021-2027(USD Million)

TABLE 40    Canada market size, by application, 2016-2020(USD Million)

TABLE 41    Canada market size, by application, 2021-2027(USD Million)

TABLE 42    Europe market size, by country, 2016-2020(USD Million)

TABLE 43    Europe market size, by country, 2021-2027(USD Million)

TABLE 44    Europe market size, by drug class, 2016-2020(USD Million)

TABLE 45    Europe market size, by drug class, 2021-2027(USD Million)

TABLE 46    Europe market size, by application, 2016-2020(USD Million)

TABLE 47    Europe market size, by application, 2021-2027(USD Million)

TABLE 48    Germany market size, by drug class, 2016-2020(USD Million)

TABLE 49    Germany market size, by drug class, 2021-2027(USD Million)

TABLE 50    Germany market size, by application, 2016-2020(USD Million)

TABLE 51    Germany market size, by application, 2021-2027(USD Million)

TABLE 52    UK market size, by drug class, 2016-2020(USD Million)

TABLE 53    UK market size, by drug class, 2021-2027(USD Million)

TABLE 54    UK market size, by application, 2016-2020(USD Million)

TABLE 55    UK market size, by application, 2021-2027(USD Million)

TABLE 56    France market size, by drug class, 2016-2020(USD Million)

TABLE 57    France market size, by drug class, 2021-2027(USD Million)

TABLE 58    France market size, by application, 2016-2020(USD Million)

TABLE 59    France market size, by application, 2021-2027(USD Million)

TABLE 60    Spain market size, by drug class, 2016-2020(USD Million)

TABLE 61    Spain market size, by drug class, 2021-2027(USD Million)

TABLE 62    Spain market size, by application, 2016-2020(USD Million)

TABLE 63    Spain market size, by application, 2021-2027(USD Million)

TABLE 64    Italy market size, by drug class, 2016-2020(USD Million)

TABLE 65    Italy market size, by drug class, 2021-2027(USD Million)

TABLE 66    Italy market size, by application, 2016-2020(USD Million)

TABLE 67    Italy market size, by application, 2021-2027(USD Million)

TABLE 68    Turkey market size, by drug class, 2016-2020(USD Million)

TABLE 69    Turkey market size, by drug class, 2021-2027(USD Million)

TABLE 70    Turkey market size, by application, 2016-2020(USD Million)

TABLE 71    Turkey market size, by application, 2021-2027(USD Million)

TABLE 72    Sweden market size, by drug class, 2016-2020(USD Million)

TABLE 73    Sweden market size, by drug class, 2021-2027(USD Million)

TABLE 74    Sweden market size, by application, 2016-2020(USD Million)

TABLE 75    Sweden market size, by application, 2021-2027(USD Million)

TABLE 76    Asia Pacific market size, by country, 2016-2020(USD Million)

TABLE 77    Asia Pacific market size, by country, 2021-2027(USD Million)

TABLE 78    Asia Pacific market size, by drug class, 2016-2020(USD Million)

TABLE 79    Asia Pacific market size, by drug class, 2021-2027(USD Million)

TABLE 80    Asia Pacific market size, by application, 2016-2020(USD Million)

TABLE 81    Asia Pacific market size, by application, 2021-2027(USD Million)

TABLE 82    China market size, by drug class, 2016-2020(USD Million)

TABLE 83    China market size, by drug class, 2021-2027(USD Million)

TABLE 84    China market size, by application, 2016-2020(USD Million)

TABLE 85    China market size, by application, 2021-2027(USD Million)

TABLE 86    India market size, by drug class, 2016-2020(USD Million)

TABLE 87    India market size, by drug class, 2021-2027(USD Million)

TABLE 88    India market size, by application, 2016-2020(USD Million)

TABLE 89    India market size, by application, 2021-2027(USD Million)

TABLE 90    Japan market size, by drug class, 2016-2020(USD Million)

TABLE 91    Japan market size, by drug class, 2021-2027(USD Million)

TABLE 92    Japan market size, by application, 2016-2020(USD Million)

TABLE 93    Japan market size, by application, 2021-2027(USD Million)

TABLE 94    Australia market size, by drug class, 2016-2020(USD Million)

TABLE 95    Australia market size, by drug class, 2021-2027(USD Million)

TABLE 96    Australia market size, by application, 2016-2020(USD Million)

TABLE 97    Australia market size, by application, 2021-2027(USD Million)

TABLE 98    South Korea market size, by drug class, 2016-2020(USD Million)

TABLE 99    South Korea market size, by drug class, 2021-2027(USD Million)

TABLE 100    South Korea market size, by application, 2016-2020(USD Million)

TABLE 101    South Korea market size, by application, 2021-2027(USD Million)

TABLE 102    New Zealand market size, by drug class, 2016-2020(USD Million)

TABLE 103    New Zealand market size, by drug class, 2021-2027(USD Million)

TABLE 104    New Zealand market size, by application, 2016-2020(USD Million)

TABLE 105    New Zealand market size, by application, 2021-2027(USD Million)

TABLE 106    Latin America market size, by country, 2016-2020(USD Million)

TABLE 107    Latin America market size, by country, 2021-2027(USD Million)

TABLE 108    Latin America market size, by drug class, 2016-2020(USD Million)

TABLE 109    Latin America market size, by drug class, 2021-2027(USD Million)

TABLE 110    Latin America market size, by application, 2016-2020(USD Million)

TABLE 111    Latin America market size, by application, 2021-2027(USD Million)

TABLE 112    Brazil market size, by drug class, 2016-2020(USD Million)

TABLE 113    Brazil market size, by drug class, 2021-2027(USD Million)

TABLE 114    Brazil market size, by application, 2016-2020(USD Million)

TABLE 115    Brazil market size, by application, 2021-2027(USD Million)

TABLE 116    Mexico market size, by drug class, 2016-2020(USD Million)

TABLE 117    Mexico market size, by drug class, 2021-2027(USD Million)

TABLE 118    Mexico market size, by application, 2016-2020(USD Million)

TABLE 119    Mexico market size, by application, 2021-2027(USD Million)

TABLE 120    Argentina market size, by drug class, 2016-2020(USD Million)

TABLE 121    Argentina market size, by drug class, 2021-2027(USD Million)

TABLE 122    Argentina market size, by application, 2016-2020(USD Million)

TABLE 123    Argentina market size, by application, 2021-2027(USD Million)

TABLE 124    MEA market size, by country, 2016-2020(USD Million)

TABLE 125    MEA market size, by country, 2021-2027(USD Million)

TABLE 126    MEA market size, by drug class, 2016-2020(USD Million)

TABLE 127    MEA market size, by drug class, 2021-2027(USD Million)

TABLE 128    MEA market size, by application, 2016-2020(USD Million)

TABLE 129    MEA market size, by application, 2021-2027(USD Million)

TABLE 130    South Africa market size, by drug class, 2016-2020(USD Million)

TABLE 131    South Africa market size, by drug class, 2021-2027(USD Million)

TABLE 132    South Africa market size, by application, 2016-2020(USD Million)

TABLE 133    South Africa market size, by application, 2021-2027(USD Million)

TABLE 134    Saudi Arabia market size, by drug class, 2016-2020(USD Million)

TABLE 135    Saudi Arabia market size, by drug class, 2021-2027(USD Million)

TABLE 136    Saudi Arabia market size, by application, 2016-2020(USD Million)

TABLE 137    Saudi Arabia market size, by application, 2021-2027(USD Million)
 

Charts & Figures

FIG 1    Antidepressant drugs industry 360º synopsis, 2016 – 2027

FIG 2    Industry segmentation

FIG 3    Global antidepressant drugs industry landscape, 2016 – 2027 (USD Million)

FIG 4    Growth potential analysis, by drug class

FIG 5    Growth potential analysis, by application

FIG 6    Porter’s analysis

FIG 7    PESTEL analysis

FIG 8    Key segment trends, by drug class

FIG 9    Key segment trends, by application

FIG 10    Key regional trends

FIG 11    Competitive dashboard, 2020